TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI April 19, 1985
TCL Archive Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research April 11, 2014
